Nabriva Therapeutics plc·4

Dec 1, 8:21 PM ET

Schranz Jennifer 4

4 · Nabriva Therapeutics plc · Filed Dec 1, 2020

Insider Transaction Report

Form 4
Period: 2020-11-30
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-11-30$0.43/sh301$129167,240 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4